Status:
RECRUITING
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
Lorraine Cancer Institute - ICL
Emille Gallé Surgical Center - CCEG
Conditions:
Soft Tissue Neoplasm
Bone Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
Detailed Description
Comparison of values relating to the texture parameters of tumors evaluated by MRI and ultra-high resolution CT between benign and malignant lesions using histological analysis as the standard of refe...
Eligibility Criteria
Inclusion
- Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging.
Exclusion
- Pregnancy
- Breast feeding patients
- Renal insufficiency
- Contra indications to MRI or CT
- Prior surgery or treatment to the evaluated lesion.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT04394052
Start Date
June 1 2020
End Date
June 1 2030
Last Update
July 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU-Nancy
Nancy, Lorraine, France, 54000